More Press Releases

View Older Stories View Newer Stories

Mar 25, 2025 04:40PM Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025

Mar 25, 2025 04:38PM True North Mortgage Welcomes 25+ Former Rocket Mortgage Canada Employees, Expands Windsor and Quebec Presence

Mar 25, 2025 04:35PM Lilly announces details of presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting

Mar 25, 2025 04:35PM IO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting

Mar 25, 2025 04:35PM Verastem Oncology Announces Multiple Presentations Focused on RAS/MAPK Pathway Inhibition at AACR Annual Meeting 2025

Mar 25, 2025 04:35PM Arcus Biosciences Announces New Employment Inducement Grants

Mar 25, 2025 04:35PM iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025

Mar 25, 2025 04:35PM Foghorn Therapeutics Announces New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and EP300 Degrader Programs at 2025 AACR Meeting

Mar 25, 2025 04:30PM Millennial Increases Private Placement

Mar 25, 2025 04:30PM How CNH's Precision Technology Is Helping Farmers Tackle Water Scarcity

Mar 25, 2025 04:31PM Aulos Bioscience to Present Promising Phase 2 Data for Novel IL-2 Therapeutic AU-007 in Melanoma at AACR Annual Meeting

Mar 25, 2025 04:31PM Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting

Mar 25, 2025 04:31PM Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting

Mar 25, 2025 04:31PM Olema Oncology to Present Preclinical Data for OP-3136, a Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at the 2025 AACR Annual Meeting

Mar 25, 2025 04:30PM Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting

Mar 25, 2025 04:30PM Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting

Mar 25, 2025 04:30PM NeOnc Technologies Holdings Announces Effectiveness of Registration Statement and Anticipated Listing Date of Common Stock on Nasdaq Global Market

Mar 25, 2025 04:30PM Oceanfoam's Eco-Friendly Tidal Roller Named an NBC Select Wellness Awards Winner

Mar 25, 2025 04:30PM Integreon Wins Legalweek 2025 Leaders in Tech Law Award for Innovation

Mar 25, 2025 04:30PM Data Cities to Build AI-Optimized Data Centers Worldwide, Breaking Ground Near San Francisco in 2025

Mar 25, 2025 04:30PM Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025

Mar 25, 2025 04:30PM Nouscom to Present Final Results from Successful Phase Ib/II Trial of NOUS-209 in People Living with Lynch Syndrome, Demonstrating Powerful Potential to Intercept Cancer in its Earliest Stages of Deve

Mar 25, 2025 04:30PM Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline with Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025

Mar 25, 2025 04:30PM Velo3D to Announce Fiscal Year 2024 Results on March 31, 2025

Mar 25, 2025 04:30PM Kulicke & Soffa Introduces New Vertical Wire Solutions to Expand Market Leadership

Mar 25, 2025 04:30PM Health in Tech Expands Access to Virtual Care Through Collaboration with DialCare

Mar 25, 2025 04:30PM Kulicke & Soffa Introduces Asterion®-PW for Power Semiconductor Applications

Mar 25, 2025 04:30PM Farmers & Merchants Bancorp, Inc. Declares 2025 First-Quarter Cash Dividend

Mar 25, 2025 04:30PM Rgenta Therapeutics Announces Presentation at the American Association for Cancer Research (AACR) 2025 Annual Meeting

Mar 25, 2025 04:30PM Media Advisory — Newport News Shipbuilding Apprentice School to Host Commencement Ceremony for 2024 Graduates

Mar 25, 2025 04:30PM CGI expands its presence in Québec City with the acquisition of Momentum Technologies

Mar 25, 2025 04:30PM Accent Therapeutics to Present Data on Lead Programs ATX-559 and ATX-295 at the 2025 American Association for Cancer Research Annual Meeting

Mar 25, 2025 04:30PM Cadence Bank Announces First Quarter 2025 Earnings Webcast Schedule

Mar 25, 2025 04:30PM Marengo to Share Updated Clinical Data of Invikafusp Monotherapy Activity in PD1 resistant tumors in a Clinical Plenary Oral Presentation at AACR 2025

Mar 25, 2025 04:30PM Nurix Therapeutics Announces Multiple Presentations at the American Association for Cancer Research (AACR) 2025 Annual Meeting

Mar 25, 2025 04:30PM Elevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025

Mar 25, 2025 04:30PM Chimera Investment Corporation Sponsors Residential Mortgage Loan Securitizations

Mar 25, 2025 04:30PM Affimed Announces Acceptance of AFM24 Abstract on Dose Optimization for Presentation at American Association for Cancer Research Annual Meeting

Mar 25, 2025 04:30PM Panera Brands Names Paul Carbone Chief Executive Officer

Mar 25, 2025 04:30PM Quanta Therapeutics Announces Late-Breaking Presentation of QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025

Mar 25, 2025 04:30PM Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025

Mar 25, 2025 04:30PM ECD Auto Design Reports Third Quarter 2024 Financial Results; Revenues Increase 30% to $6.4 Million

Mar 25, 2025 04:30PM CLEAR and American Express Renew Partnership to Provide Premium Travel Experiences at Airports to Card Members

Mar 25, 2025 04:30PM Farmers & Merchants Bancorp, Inc. Declares 2025 First-Quarter Cash Dividend

Mar 25, 2025 04:30PM Coherus to Present Data from a Phase 1 Dose Expansion Study of CHS-114, a Cytolytic Antibody Targeting Chemokine Receptor 8 (CCR8), at the 2025 American Association for Cancer Research (AACR) Annual M

Mar 25, 2025 04:30PM Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Mar 25, 2025 04:30PM Tempest Announces Amezalpat Poster Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting

Mar 25, 2025 04:30PM ORIC® Pharmaceuticals Announces ORIC-944 Preclinical Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting

Mar 25, 2025 04:30PM AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Mar 25, 2025 04:30PM T-knife Therapeutics Announces Five Presentations at American Association for Cancer Research (AACR) Annual Meeting

View Newer Stories View Older Stories